GL
GlycoMimetics
GLYC·NASDAQRockville MDFounded 200340 employees
Micro CapbiotechPublicHematology
Platform: Uproleselan AML
Market Cap
$0.02B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (GLYC)
Loading GLYC stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| GLY-2161 | GLY-2161 | Phase 1/2 | 2 | PD-L1 | TTR AmyloidosisEoE | ||
| GLY-5612 | GLY-5612 | Phase 3 | 1 | FXIa | MS |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (2)